ISOPROTERENOL IMPAIRS THE RAT CORONARY VASCULATURE - EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION

被引:3
|
作者
ROUX, S
CLOZEL, JP
FISCHLI, W
KUHN, H
机构
关键词
ISOPROTERENOL; ACE INHIBITION; CILAZAPRIL; VASCULAR REMODELING; CORONARY RESERVE; CORONARY BLOOD FLOW; MYOCARDIAL NECROSIS;
D O I
10.1097/00005344-199204000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of the present study was to evaluate whether in addition to its myocardial effects, chronic beta-adrenergic stimulation with isoproterenol could modify the coronary vasculature. For this purpose, rats were treated for 2 weeks with isoproterenol, and the hearts were isolated for determination of the minimal coronary vascular resistance under maximal vasodilation and then perfused-fixed for morphometry of the coronary arteries. In addition, because isoproterenol stimulates the reninangiotensin system (RAS), the effects of angiotensin-converting enzyme (ACE) inhibition on the coronary vasculature were assessed. Isoproterenol increased heart weight by 65% and minimal coronary resistance by 55%. This effect was associated with medial thickening in intermediate (32%) and large coronary arterioles (26%). Cilazapril, a long-acting ACE inhibitor, completely prevented the medial thickening induced by isoproterenol and normalized the minimal coronary resistance. We conclude that impairment of the rat coronary vasculature induced by chronic beta-adrenergic stimulation might be in part mediated by activation of the RAS.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 50 条
  • [41] EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON CARDIAC COLLAGEN IN HYPERTENSIVE AND NORMOTENSIVE RATS
    WHY, HJF
    PATEL, VB
    RICHARDSON, PJ
    PREEDY, VR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (03) : S345 - S345
  • [42] RENAL EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CONGESTIVE HEART-FAILURE
    GOTTLIEB, SS
    WEIR, MR
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (11): : D14 - D21
  • [43] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH FOSINOPRIL SODIUM IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY
    DESMET, W
    VROLIX, M
    DESCHEERDER, I
    VANLIERDE, J
    WILLEMS, JL
    PIESSENS, J
    CIRCULATION, 1994, 89 (01) : 385 - 392
  • [44] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION - RESEARCH ADVANCES AND CLINICAL IMPLICATIONS
    SWALES, JD
    DZAU, VJ
    AMERICAN HEART JOURNAL, 1992, 123 (05) : 1412 - 1413
  • [45] INFLUENCE OF CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON ANESTHETIC INDUCTION
    CORIAT, P
    RICHER, C
    DOURAKI, T
    GOMEZ, C
    HENDRICKS, K
    GIUDICELLI, JF
    VIARS, P
    ANESTHESIOLOGY, 1994, 81 (02) : 299 - 307
  • [46] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION PARTIALLY PREVENTS DIABETIC ORGANOMEGALY
    HAJINAZARIAN, M
    COSIO, FG
    NAHMAN, NS
    MAHAN, JD
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (01) : 105 - 117
  • [47] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION - NEW MEDICAL THERAPY FOR HYPERTENSION
    FAVRE, L
    HOLLIFIELD, JW
    MCKINSTRY, DN
    JOURNAL OF THE TENNESSEE MEDICAL ASSOCIATION, 1978, 71 (03): : 201 - 202
  • [48] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    KRAMER, HJ
    PREDEL, HG
    MEYERLEHNERT, H
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1990, 8 : 16 - 24
  • [49] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION - COMPARISON BETWEEN IDRAPRIL AND CAPTOPRIL
    STEINHAUSLIN, F
    BUCLIN, T
    NUSSBERGER, J
    CRISCUOLI, M
    CAPONE, P
    BRUNNER, HR
    BIOLLAZ, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 204 - 204
  • [50] ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN ANGINA-PECTORIS
    DEGRAEFF, PA
    VANGILST, WH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S30 - S37